Nasdaq · CIK 0001816590
CMPS COMPASS Pathways plc
Insider trading from SEC Form 4. Last filing Oct 31, 2025.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
15
with a Form 4 at this company
Signals
Open-market buys and sells at COMPASS Pathways plc, scored.
No scored open-market trades yet. Grants, exercises and other rows are below.
Transactions
The last 23 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 29, 2025 | Jeffrey M Jonas director | AGrant or award Share Option (Right to Buy)derivative | +52,000 | $0.00 | $0 | 52,000 | Oct 31, 2025 |
| Aug 1, 2025 | Kabir Nath Chief Executive Officer | FTax withholding Ordinary Shares | -6,366 | $4.34 | $28k | 221,302 | Aug 4, 2025 |
| Jul 29, 2025 | Justin D. Gover director | AGrant or award Share Option (Right to Buy)derivative | +52,000 | $0.00 | $0 | 52,000 | Jul 30, 2025 |
| Jun 12, 2025 | Annalisa Jenkins director | AGrant or award Share Option (Right to Buy)derivative | +26,000 | $0.00 | $0 | 26,000 | Jun 13, 2025 |
| Jun 12, 2025 | Daphne Karydas director | AGrant or award Share Option (Right to Buy)derivative | +26,000 | $0.00 | $0 | 26,000 | Jun 13, 2025 |
| Jun 12, 2025 | Thomas Lonngren director | AGrant or award Share Option (Right to Buy)derivative | +26,000 | $0.00 | $0 | 26,000 | Jun 13, 2025 |
| Jun 12, 2025 | Linda McGoldrick director | AGrant or award Share Option (Right to Buy)derivative | +26,000 | $0.00 | $0 | 26,000 | Jun 13, 2025 |
| Jun 12, 2025 | Robert McQuade director | AGrant or award Share Option (Right to Buy)derivative | +26,000 | $0.00 | $0 | 26,000 | Jun 13, 2025 |
| Jun 12, 2025 | David Y Norton director | AGrant or award Share Option (Right to Buy)derivative | +26,000 | $0.00 | $0 | 26,000 | Jun 13, 2025 |
| Jun 12, 2025 | Wayne Joseph Riley director | AGrant or award Share Option (Right to Buy)derivative | +26,000 | $0.00 | $0 | 26,000 | Jun 13, 2025 |
| Jun 12, 2025 | Gino Santini director | AGrant or award Share Option (Right to Buy)derivative | +39,000 | $0.00 | $0 | 39,000 | Jun 13, 2025 |
| Mar 11, 2025 | Kabir Nath Chief Executive Officer | AGrant or award Ordinary Shares | +92,000 | $0.00 | $0 | 227,668 | Mar 13, 2025 |
| Mar 11, 2025 | Guy Goodwin Chief Medical Officer | AGrant or award Share Option (Right to Buy)derivative | +32,000 | $0.00 | $0 | 32,000 | Mar 13, 2025 |
| Mar 11, 2025 | Teri Loxam Chief Financial Officer | AGrant or award Ordinary Shares | +25,000 | $0.00 | $0 | 83,250 | Mar 13, 2025 |
| Mar 11, 2025 | Teri Loxam Chief Financial Officer | AGrant or award Share Option (Right to Buy)derivative | +76,000 | $0.00 | $0 | 76,000 | Mar 13, 2025 |
| Mar 11, 2025 | Kabir Nath Chief Executive Officer | AGrant or award Share Option (Right to Buy)derivative | +275,000 | $0.00 | $0 | 275,000 | Mar 13, 2025 |
| Mar 11, 2025 | Guy Goodwin Chief Medical Officer | AGrant or award Share Option (Right to Buy)derivative | +63,000 | $0.00 | $0 | 63,000 | Mar 13, 2025 |
| Mar 3, 2025 | Teri Loxam Chief Financial Officer | FTax withholding Ordinary Shares | -4,468 | $3.67 | $16k | 58,250 | Mar 4, 2025 |
| Feb 3, 2025 | Kabir Nath Chief Executive Officer | FTax withholding Ordinary Shares | -15,516 | $4.31 | $67k | 135,668 | Feb 5, 2025 |
| Oct 24, 2024 | George Jay Goldsmith owner | SOpen-market sale Ordinary Shares | -776,565 | - | - | 3,155,122 | Oct 25, 2024 |
| Oct 24, 2024 | Ekaterina Malievskaia owner | SOpen-market sale Ordinary Shares | -776,565 | - | - | 3,152,848 | Oct 25, 2024 |
| Oct 24, 2024 | George Jay Goldsmith owner | SOpen-market sale Ordinary Sharesindirect: By: Spouse | -776,565 | - | - | 3,152,848 | Oct 25, 2024 |
| Oct 24, 2024 | Ekaterina Malievskaia owner | SOpen-market sale Ordinary Sharesindirect: By: Spouse | -776,565 | - | - | 3,155,122 | Oct 25, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- George Jay Goldsmithowner
- Guy GoodwinChief Medical Officer
- Justin D. Goverdirector
- Jeffrey M Jonasdirector
- Annalisa Jenkinsdirector
- Daphne Karydasdirector
- Thomas Lonngrendirector
- Teri LoxamChief Financial Officer
- Ekaterina Malievskaiaowner
- Linda McGoldrickdirector
- Robert McQuadedirector
- Kabir NathChief Executive Officer
- David Y Nortondirector
- Wayne Joseph Rileydirector
- Gino Santinidirector
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.